Table 1 AUROC of baseline BCL-2 dependence for the prediction of treatment response and outcome
FEATURE | AUROC (VALUE) | AUROC (SD) | TREATMENT TIMEPOINT | RESPONSE (AREA) |
|---|---|---|---|---|
ABT199 (1 μM) | 0.802 | 0.082 | Post Cycle 3 | MRD PB |
ABT199 (1 μM) | 0.783 | 0.117 | Post FCR | MRD PB |
ABT199 (0.1 μM) | 0.773 | 0.118 | Post FCR | MRD PB |
BAD (0.1 μM) | 0.760 | 0.112 | Post FCR | MRD PB |
ABT199 (0.5 μM) | 0.752 | 0.133 | Post FCR | MRD PB |